The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation

Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernandez RS, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ
Record ID 32010000264
English
Authors' recommendations: Review finds that surveillance following treatment of primary breast cancer is likely to improve patient survival, with a strategy of mammography alone every 12–24 months appearing to have the highest net benefits. To optimise the use of resources and achieve maximum patient benefit, women at a higher risk of developing ipsilateral breast tumour recurrence or metachronous contralateral breast cancer should be offered more comprehensive and more frequent surveillance.
Details
Project Status: Completed
URL for project: http://www.hta.ac.uk/1709
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Mammography
Contact
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: 2011 Queen’s Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.